missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human SorLA (aa 82-753) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marke: R&D Systems™ 9880-LA-050
622.02 CHF gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
The Recombinant Human SorLA (aa 82-753) Protein is derived from HEK293. The Recombinant Human SorLA (aa 82-753) Protein has been validated for the following applications: Bioactivity.Spezifikation
| Q92673 | |
| Lyophilized from a 0.2 μm filtered solution in PBS. | |
| 76 kDa | |
| Human embryonic kidney cell, HEK293-derived human SorLA protein Ser82-Pro753, with a C-terminal 6-His tag | |
| RUO | |
| Unconjugated | |
| Human | |
| >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Bioactivity | |
| 6653 | |
| 50 μg | |
| 12 months from date of receipt, ≤ -20°C as supplied; 1 month, 2 to 8°C under sterile conditions after reconstitution; 3 months, ≤ -20°C under sterile conditions after reconstitution. | |
| <0.10 EU per 1 μg of the protein by the LAL method. | |
| SorLA | |
| Reconstitute at 1 mg/mL in PBS. |